Amanda J. Ribbands
Bollington, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Real-World Treatment Patterns for Patients with High-Risk Biochemically Recurrent Nonmetastatic Castration‑Sensitive Prostate Cancer.
Journal: Advances in therapy
Published: November 19, 2025
Criteria Clinicians Use to Classify Patients as High Risk in Biochemically Recurrent Nonmetastatic Castration‑Sensitive Prostate Cancer.
Journal: Advances in therapy
Published: November 19, 2025
Embedding genetic testing in the metastatic prostate cancer pathway: understanding patient and physician perspectives.
Journal: Future oncology (London, England)
Published: October 31, 2025
Real-world treatment patterns and genetic testing in a metastatic castration-resistant prostate cancer setting in Europe.
Journal: Future oncology (London, England)
Published: March 19, 2025
Treatment landscape and disease burden of patients with multiple myeloma in Japan: a real-world survey.
Journal: Future oncology (London, England)
Published: February 04, 2025
Physician Reasons for or Against Treatment Intensification in Patients With Metastatic Prostate Cancer.
Journal: JAMA network open
Published: December 09, 2024
Real-world treatment patterns, healthcare resource use and disease burden in patients with multiple myeloma in Europe.
Journal: Future oncology (London, England)
Published: September 14, 2023
Drivers of physician decision-making and patient perspectives across lines of therapy in multiple myeloma in the USA.
Journal: Future oncology (London, England)
Published: June 07, 2023
Real-world patient-reported outcomes and concordance between patient and physician reporting of side effects across lines of therapy in multiple myeloma within the USA.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: January 04, 2023
Real-World Treatment Patterns Among Patients With Metastatic Castration-Resistant Prostate Cancer: Results From an International Study.
Journal: The oncologist
Published: August 22, 2022
Real-World Treatment Trends Among Patients with Metastatic Castration-Sensitive Prostate Cancer: Results from an International Study.
Journal: The oncologist
Published: August 22, 2022
Real-world homologous recombination repair mutation testing in metastatic castration-resistant prostate cancer in the USA, Europe and Japan.
Journal: Future oncology (London, England)
Published: January 19, 2022
Last Updated: 09/26/2026